BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM
$324M
1-Year Est. Return
47.35%
This Fund
S&P 500
1 Year Est. Return
+47.35%
AUM
$322M
AUM Growth
+$12.3M
(+4%)
Holding
80
Top Buys
| 1 | +$12.2M | |
| 2 | +$5.01M | |
| 3 | +$4.09M | |
| 4 |
Larimar Therapeutics
LRMR
|
+$3.47M |
| 5 |
Immuneering
IMRX
|
+$2.85M |
Top Sells
| 1 | +$15.9M | |
| 2 | +$15.2M | |
| 3 | +$5.09M | |
| 4 |
Mineralys Therapeutics
MLYS
|
+$5.08M |
| 5 |
Tango Therapeutics
TNGX
|
+$4.7M |
Sector Composition
| 1 | Healthcare | 56.77% |
| 2 | Financials | 22.9% |
| 3 | Technology | 12.32% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Energy | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Starwood Property Trust
STWD
$6.43B
| – | – |
-131,461
|
|
||
77
Katapult Holdings
KPLT
$31M
| – | – |
-5,421
|
|
||
78
Cabaletta Bio
CABA
$282M
| – | – |
-1,125,000
|
|
||
79
Biomea Fusion
BMEA
$92.5M
| – | – |
-1,300,000
|
|
||
80
Apogee Therapeutics
APGE
$5.78B
| – | – |
-35,000
|
|